Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells

被引:80
作者
Wang, GH
Mitsui, K
Kotliarova, S
Yamashita, A
Nagao, Y
Tokuhiro, S
Iwatsubo, T
Kanazawa, I
Nukina, N
机构
[1] RIKEN, Brain Sci Inst, Lab CAG REpeat Dis, Wako, Saitama 3510198, Japan
[2] Univ Tokyo, Dept Neurol, Tokyo, Japan
[3] Univ Tokyo, Dept Neuropathol & Neurosci, Tokyo, Japan
关键词
apoptosis; CAG repeat disease; caspase; huntingtin; huntington disease; inhibitor of caspase-activated DNase (ICAD); lamin B; polyglutamine;
D O I
10.1097/00001756-199908200-00001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
HUNTINGTON disease (HD) is an autosomal dominant neurodegenerative disorder. To investigate the mechanism of neurodegeneration induced by mutant huntingtin, we developed a stable neuro2a cell line expressing truncated N-terminal huntingtin (tNhtt) with EGFP using the ecdysone-inducible system. The formation of aggregates and the cell death induced by expression of tNhtt with expanded polyglutamine was repeat length-and dose-dependent. Caspases were activated, and the death substrates of caspases, lamin B and ICAD (an inhibitor of caspase-activated DNase), were cleaved in this cell death process. The cleavage of lamin B was inhibited by caspase inhibitors. These findings suggest that the cell death induced by tNhtt with expanded polyglutamine is mediated by caspases.
引用
收藏
页码:2435 / 2438
页数:4
相关论文
共 19 条
[1]   Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability [J].
Cooper, AJL ;
Sheu, KFR ;
Burke, JR ;
Strittmatter, WJ ;
Gentile, V ;
Peluso, G ;
Blass, JP .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :889-899
[2]   Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture [J].
Cooper, JK ;
Schilling, G ;
Peters, MF ;
Herring, WJ ;
Sharp, AH ;
Kaminsky, Z ;
Masone, J ;
Khan, FA ;
Delanoy, M ;
Borchelt, DR ;
Dawson, VL ;
Dawson, TM ;
Ross, CA .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :783-790
[3]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[4]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[5]   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50
[6]   In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains [J].
FernandesAlnemri, T ;
Armstrong, RC ;
Krebs, J ;
Srinivasula, SM ;
Wang, L ;
Bullrich, F ;
Fritz, LC ;
Trapani, JA ;
Tomaselli, KJ ;
Litwack, G ;
Alnemri, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7464-7469
[7]   In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease [J].
Hackam, AS ;
Singaraja, R ;
Zhang, TQ ;
Gan, L ;
Hayden, MR .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :25-33
[8]   A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES [J].
MACDONALD, ME ;
AMBROSE, CM ;
DUYAO, MP ;
MYERS, RH ;
LIN, C ;
SRINIDHI, L ;
BARNES, G ;
TAYLOR, SA ;
JAMES, M ;
GROOT, N ;
MACFARLANE, H ;
JENKINS, B ;
ANDERSON, MA ;
WEXLER, NS ;
GUSELLA, JF ;
BATES, GP ;
BAXENDALE, S ;
HUMMERICH, H ;
KIRBY, S ;
NORTH, M ;
YOUNGMAN, S ;
MOTT, R ;
ZEHETNER, G ;
SEDLACEK, Z ;
POUSTKA, A ;
FRISCHAUF, AM ;
LEHRACH, H ;
BUCKLER, AJ ;
CHURCH, D ;
DOUCETTESTAMM, L ;
ODONOVAN, MC ;
RIBARAMIREZ, L ;
SHAH, M ;
STANTON, VP ;
STROBEL, SA ;
DRATHS, KM ;
WALES, JL ;
DERVAN, P ;
HOUSMAN, DE ;
ALTHERR, M ;
SHIANG, R ;
THOMPSON, L ;
FIELDER, T ;
WASMUTH, JJ ;
TAGLE, D ;
VALDES, J ;
ELMER, L ;
ALLARD, M ;
CASTILLA, L ;
SWAROOP, M .
CELL, 1993, 72 (06) :971-983
[9]  
Moulder KL, 1999, J NEUROSCI, V19, P705
[10]  
NEAMATI N, 1995, J IMMUNOL, V154, P3788